Repurposed Drug Could Open Door to More Stem Cell Transplants

This is Peter Zandstra, director of UBC’s School of Biomedical Engineering and Michael Smith Laboratories, and chief scientific officer of the Centre for Commercialization of Regenerative Medicine. Credit: UBC/Paul Joseph